Cargando…

Lack of association between Screencell-detected circulating tumour cells and long-term survival of patients undergoing surgery for non-small cell lung cancer: A pilot clinical study

Circulating tumour cells (CTCs) are cancer cells of epithelial origin that are present in peripheral blood samples. ScreenCell detection of CTCs and the association with long term survival in non-small cell lung cancer (NSCLC) patients was evaluated in the present study. A total of 33 patients under...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barr, James, Chudasama, Dimple, Rice, Alex, Karteris, Emmanouil, Anikin, Vladimir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016525/ https://www.ncbi.nlm.nih.gov/pubmed/32064093 http://dx.doi.org/10.3892/mco.2020.1981

Ejemplares similares

Perioperative detection of circulating tumour cells in patients with lung cancer
por: Chudasama, Dimple, et al.
Publicado: (2017)

Detection of Abundant Non-Haematopoietic Circulating Cancer-Related Cells in Patients with Advanced Epithelial Ovarian Cancer
por: Kumar, Juhi, et al.
Publicado: (2019)

Circulating tumour cells and circulating cell-free DNA in patients with lung cancer: a comparison between thoracotomy and video-assisted thoracoscopic surgery
por: Katopodis, Periklis, et al.
Publicado: (2021)

Kinase Inhibitors and Ovarian Cancer
por: Katopodis, Periklis, et al.
Publicado: (2019)

Prognostic value of the DNA integrity index in patients with malignant lung tumors
por: Chudasama, Dimple Y., et al.
Publicado: (2018)

Liquid Biopsies in Lung Cancer: Four Emerging Technologies and Potential Clinical Applications
por: Chudasama, Dimple, et al.
Publicado: (2019)

Identification of cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers
por: Chudasama, Dimple, et al.
Publicado: (2018)

Differential Expression of RAD51AP1 in Ovarian Cancer: Effects of siRNA In Vitro
por: Filipe, Alice, et al.
Publicado: (2022)

Differential effects of rapalogues, dual kinase inhibitors on human ovarian carcinoma cells in vitro
por: ROGERS-BROADWAY, KARLY-RAI, et al.
Publicado: (2016)

Pan-cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS-CoV-2 infection leading to COVID-19
por: Katopodis, Periklis, et al.
Publicado: (2020)

In Silico and In Vitro Analysis of lncRNA XIST Reveals a Panel of Possible Lung Cancer Regulators and a Five-Gene Diagnostic Signature
por: Katopodis, Periklis, et al.
Publicado: (2020)

Identification of Cancer-Associated Circulating Cells in Anal Cancer Patients
por: Carter, Thomas J., et al.
Publicado: (2020)

Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal
por: Gradilone, Angela, et al.
Publicado: (2011)

COVID-19 and SARS-CoV-2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease
por: Katopodis, Periklis, et al.
Publicado: (2021)

Identification of RAD51 foci in cancer-associated circulating cells of patients with high-grade serous ovarian cancer: association with treatment outcomes
por: Alizzi, Zena, et al.
Publicado: (2023)

Comparison of Circulating Tumour Cells and Circulating Cell-Free Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy
por: Vo, Jess Honganh, et al.
Publicado: (2016)

Development of a dual energy CT based model to assess response to treatment in patients with high grade serous ovarian cancer: a pilot cohort study
por: Alizzi, Zena, et al.
Publicado: (2023)

Circulating tumour cells in regionally metastatic cutaneous squamous cell carcinoma: A pilot study
por: Morosin, Tia, et al.
Publicado: (2016)

Expression of circulating tumour cells in oral squamous cell carcinoma: An ex vivo pilot study
por: Sahana, N S, et al.
Publicado: (2023)

Modelling Circulating Tumour Cells for Personalised Survival Prediction in Metastatic Breast Cancer
por: Ascolani, Gianluca, et al.
Publicado: (2015)

Squeezing through the microcirculation: survival adaptations of circulating tumour cells to seed metastasis
por: Perea Paizal, Julia, et al.
Publicado: (2020)

Circulating Tumour Cells as an Independent Prognostic Factor in Patients with Advanced Oesophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy
por: Su, Po-Jung, et al.
Publicado: (2016)

Circulating tumour cells and tumour biomarkers in functional midgut neuroendocrine tumours
por: Meyer, Tim, et al.
Publicado: (2022)

Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients
por: Weigelt, B, et al.
Publicado: (2003)

Unbiased and Automated Identification of a Circulating Tumour Cell Definition That Associates with Overall Survival
por: Ligthart, Sjoerd T., et al.
Publicado: (2011)

Circulating tumour cells predict survival in gastric cancer patients: a meta-analysis
por: Wang, Hui-Yu, et al.
Publicado: (2016)

Micronucleus formation in human tumour cells: lack of correlation with radiosensitivity.
por: Bush, C., et al.
Publicado: (1993)

A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker
por: Khoja, L, et al.
Publicado: (2012)

Long term survival following the detection of circulating tumour cells in head and neck squamous cell carcinoma
por: Winter, Stuart C, et al.
Publicado: (2009)

The molecular detection of circulating tumour cells.
por: Johnson, P. W., et al.
Publicado: (1995)

Biosensors for the Detection of Circulating Tumour Cells
por: Costa, Clotilde, et al.
Publicado: (2014)

Circulating tumour cells in breast cancer
por: Krawczyk, Natalia, et al.
Publicado: (2013)

Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer—An Update
por: Kapeleris, Joanna, et al.
Publicado: (2022)

Not only ACE2—the quest for additional host cell mediators of SARS-CoV-2 infection: Neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19
por: Kyrou, Ioannis, et al.
Publicado: (2021)

Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours
por: Sefrioui, David, et al.
Publicado: (2017)

Isolation of Circulating Tumour Cells in Patients With Glioblastoma Using Spiral Microfluidic Technology – A Pilot Study
por: Müller Bark, Juliana, et al.
Publicado: (2021)

Cytology and cell‐block immunohistochemistry of circulating tumour cells
por: Mayall, Frederick George, et al.
Publicado: (2019)

Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours
por: Rizzo, Francesca M., et al.
Publicado: (2019)

Diagnostic technologies for circulating tumour cells and exosomes
por: Shao, Huilin, et al.
Publicado: (2016)

Elevated Circulating Lactate Levels and Widespread Expression of Its Cognate Receptor, Hydroxycarboxylic Acid Receptor 1 (HCAR1), in Ovarian Cancer
por: Kerslake, Rachel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7one1hbmo9o7n22t4vun9a22mp